Belmont Global Advisors »

Fate Therapeutics shares owned by Belmont Global Advisors

Quarter-by-quarter ownership of Fate Therapeutics (FATE) shares owned by Belmont Global Advisors from 13F filings

Historical chart of Belmont Global Advisors investment in Fate Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Fate Therapeutics held by Belmont Global Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fate Therapeutics by Belmont Global Advisors

Quarter filed Position value Share count Share price at filing
2016-09-30 $468k 150k 3.12
2016-06-30 $680k 400k 1.70
2016-03-31 $868k 482k 1.80
2015-12-31 $556k 165k 3.37